The U.S. Judicial Panel on Multidistrict Litigation has consolidated cases in Abilify, Talc and Taxotere suits among others.
The Talc litigation has been transferred to New Jersey judge Freda Wolfson. She currently presides over Chakalos v. Johnson & Johnson, filed in November 2014 making it the most advanced suit. New Jersey is also the home to defendant Johnson & Johnson. Eleven pending cases and 43 potential actions from around the country were transferred. The talc claims allege that the plaintiffs suffered personal injuries or wrongful death as a result of ovarian or uterine cancer due to application of talcum powder to their genitals. Some of the suits claim that research has linked talc to cancer since the 1960s and the manufacturers were aware of the risk yet failed to warn customers.
Abilify Gambling Suits have been consolidated in Florida’s Northern District in Pensacola under Chief District Judge M. Casey Rodgers. Judge Rodgers is already presiding over two Abilify cases in that state. Twenty-two actions pending in 12 districts will be transferred. Abilify is widely used to treat patients with schizophrenia and other disorders. The suits claim that the manufacturer, Bristol-Myers Squibb co. failed to warn that the drug could cause pathological gambling.
Taxotere permanent hair loss Suits have been consolidated in the Eastern District of Louisiana before Judge Lance M. Africk. There are currently ten actions pending in that court. The suits claim that Taxotere (docetaxel) a chemotherapy drug, causes permanent hair loss and that defendants were aware of this side effect and failed to warn patients. Additionally the drug was marketed as more effective than other chemotherapy drugs when other drugs were equally effective without the associated permanent hair loss.
Showard Law Firm is currently accepting Taxotere, Abilify and Talc claims. If you or a loved one has suffered injury as a result of any drug or medical device contact Showard Law Firm today for a free consultation.
